Browse studies

Find your next paid study

1 recruiting study matching your filters

A Phase 2 Multi-center, Randomized, Open-label Study to Assess the Efficacy and Safety of AHB-137 in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B in the North America and Europe Regions

This study is a randomized, open-label, multicenter phase 2 clinical trial to evaluate the efficacy and safety of AHB-137 injection in participants with CHB tr…

Hepatitis B, Chronic

Estimated

~$10 – $8,750

AusperBio Therapeutics Inc.NCT07654283